- « Previous
- Clinical Pharmacology
- Next »
Pergonal
Clinical Pharmacology
Clinical Pharmacology
Pergonal
61 (93.8)
55 (91.7)
58 (89.2)
51 (85.0)
31(47.7)
35 (58.3)
25 (38.5)
30 (50.0)
24 (36.9)1
29 (48.3)2
- 1 Continuing pregnancies included 14 single, 7 twins, and 3 triplet pregnancies.
- 2 Continuing pregnancies included 14 single, 9 twins, 3 triplets, and 3 quadruplet pregnancies.
- 3 Total of 34 live births. One spontaneous abortion. The follow-up data is not available for one patient.
- 4 Total of 39 live births. Two spontaneous abortions. The follow-up data is not available for two patients.
Table 3: Efficacy Outcomes by Treatment Groups in Ovulation Induction (one cycle of treatment)
| Parameter | Repronex IM N= 36 | Repronex SC N= 36 | |
| Ovulation (%) | 23 (63.9) | 25 (69.4) | |
| Received hCG (%) | 25 (69.4) | 27 (75.0) | |
| Mean Peak Serum E2 (SD) | 1158.5 (742.3) | Brand Name: Pergonal
Generic Name: Menotropins
Women's HealthFind out what women really need.
|
